Feber Andrew, Worth Daniel C, Chakravarthy Ankur, de Winter Patricia, Shah Kunal, Arya Manit, Saqib Muhammad, Nigam Raj, Malone Peter R, Tan Wei Shen, Rodney Simon, Freeman Alex, Jameson Charles, Wilson Gareth A, Powles Tom, Beck Stephan, Fenton Tim, Sharp Tyson V, Muneer Asif, Kelly John D
UCL Cancer Institute, University College London, London, United Kingdom.
Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
Cancer Res. 2016 Aug 15;76(16):4720-4727. doi: 10.1158/0008-5472.CAN-15-3134. Epub 2016 Jun 20.
Other than an association with HPV infection, little is known about the genetic alterations determining the development of penile cancer. Although penile cancer is rare in the developed world, it presents a significant burden in developing countries. Here, we report the findings of whole-exome sequencing (WES) to determine the somatic mutational landscape of penile cancer. WES was performed on penile cancer and matched germline DNA from 27 patients undergoing surgical resection. Targeted resequencing of candidate genes was performed in an independent 70 patient cohort. Mutation data were also integrated with DNA methylation and copy-number information from the same patients. We identified an HPV-associated APOBEC mutation signature and an NpCpG signature in HPV-negative disease. We also identified recurrent mutations in the novel penile cancer tumor suppressor genes CSN1(GPS1) and FAT1 Expression of CSN1 mutants in cells resulted in colocalization with AGO2 in cytoplasmic P-bodies, ultimately leading to the loss of miRNA-mediated gene silencing, which may contribute to disease etiology. Our findings represent the first comprehensive analysis of somatic alterations in penile cancer, highlighting the complex landscape of alterations in this malignancy. Cancer Res; 76(16); 4720-7. ©2016 AACR.
除了与HPV感染有关联外,对于决定阴茎癌发生发展的基因改变知之甚少。尽管阴茎癌在发达国家较为罕见,但在发展中国家却是一个重大负担。在此,我们报告全外显子组测序(WES)的结果,以确定阴茎癌的体细胞突变图谱。对27例接受手术切除的患者的阴茎癌组织及其匹配的种系DNA进行了WES。在一个独立的70例患者队列中对候选基因进行了靶向重测序。突变数据还与来自同一患者的DNA甲基化和拷贝数信息进行了整合。我们在HPV阴性疾病中鉴定出一种与HPV相关的APOBEC突变特征和一种NpCpG特征。我们还在新发现的阴茎癌肿瘤抑制基因CSN1(GPS1)和FAT1中鉴定出复发性突变。CSN1突变体在细胞中的表达导致其与AGO2在细胞质P小体中共定位,最终导致miRNA介导的基因沉默丧失,这可能有助于疾病的病因学研究。我们的研究结果代表了对阴茎癌体细胞改变的首次全面分析,突出了这种恶性肿瘤中改变的复杂图谱。《癌症研究》;76(16);4720 - 7。©2016美国癌症研究协会。